It’s in the genes
A second Cambridge-based medical bioinformatics organisation has selected BizFlakes for a staff benefit management solution.
The first, Phoremost, produces a phenotypic screening platform which aims to identify new treatments for cancer and other diseases. Its benefit scheme came into effect last month and saw take-up rates of over 90%.
Design of the Repositive benefit scheme began last month for benefits to come into effect by 1st October.